Profile: Goodwin Biotechnology, Inc. is a fully integrated cGMP contract manufacturing organization (CMO) of monoclonal antibodies and recombinant proteins for preclinical & clinical trials. We offer services that include clinical trial distribution, viral clearance study, purification process development, cell banking and cell line characterization. Our process development services range from the creation of up and downstream processes sufficient for the manufacturing of proof of concept or toxicology product material to processes for licensed manufacturing. We provide GMP compliant cell banking services that include manufacturing of seed, master, working and post-production banks. Bank sizes up to 200 vials can be manufactured. We are utilizing three different bioreactor technologies for the manufacturing of MAbs (IgGs and IgMs) and recombinant proteins.